CDTX - Cidara Therapeutics Stock Trading
Cidara Therapeutics Inc. Company Name:
CDTX Stock Symbol:
NASDAQ Market:
Cidara Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
SAN DIEGO, April 07, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced that Jeffrey Stein, Ph....
-
Collaboration includes exclusive worldwide rights to Cidara’s CD388 and other influenza Antiviral Conjugates (AVCs) for up to $780 million in upfront, milestone payments and R&D funding Cidara to advance CD388 through Phase 2 development funded by Janssen Conf...
-
SAN DIEGO, April 01, 2021 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections, today announced that the Compens...
Important Investor News Alert (OTCMKTS: ASCK)
-
GOLDENDALE, Wash., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Auscrete Corporation (OTC: ASCK) (the “Company”) announced that earlier this month, Auscrete’s CEO, John Sprovieri was asked to address a meeting of WUHAG (Western US Housing Assist Group) in Vancouver, WA. This newly...